Red Light Treatment in Peripheral Artery Disease
NCT: NCT03203239 · RECRUITING
Publicidade
ID NCTNCT03203239
EstadoRECRUITING
Data de início2018-01-17
Conclusão2028-12-31
Resumo breve
Subjects with a known diagnosis of peripheral artery disease as measured by an abnormal ankle brachial index (\<.9 or \>1.1) will undergo a single 5 min exposure of 670 nm light, 1 cm above the gastrocnemius muscle. Blood flow will be measured by infusion of ultrasound contrast and subsequent acquisition of ultrasound images. 2 blood samples will be collected for measurement of nitric oxide metabolites.
Fonte oficial
Ver no ClinicalTrials.gov →Dados provenientes da API do ClinicalTrials.gov. Para consultar o estado mais recente, veja o registo oficial.